
Analysts: ARDX stock price target of 14 in 12 months
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Ardelyx Inc’s recent filing unveils that its Director MOTT DAVID M acquired Company’s shares for reported $0.73 million on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Ardelyx Inc revealed its Director MOTT DAVID M acquired Company’s shares for reported $0.73 million on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Ardelyx Inc revealed its Director MOTT DAVID M acquired Company’s shares for reported $0.73 million on Jun
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Ardelyx Inc’s filing revealed that its Director MOTT DAVID M acquired Company’s shares for reported $0.73 million on Jun 16
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Ardelyx, Inc., a biopharmaceutical company, closed Monday’s regular session at $1.17 after surging 9.35% during the day. In the premarket